Clearside Biomedical (CLSD)
NASDAQ:CLSD
Holding CLSD?
Track your performance easily

Clearside Biomedical (CLSD) Financial Statements

935 Followers

Clearside Biomedical Financial Overview

Clearside Biomedical's market cap is currently ―. The company's EPS TTM is $-0.497; its P/E ratio is -2.62; Clearside Biomedical is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 90.00K$ 230.00K$ 6.34M$ 859.00K$ 1.02M
Gross Profit$ 90.00K$ 230.00K$ 6.34M$ 717.00K$ 805.00K
EBIT$ -7.59M$ -9.36M$ -2.56M$ -6.64M$ -6.81M
EBITDA$ -7.55M$ -9.33M$ -2.54M$ -6.63M$ -6.80M
Net Income Common Stockholders$ -7.59M$ -11.76M$ -4.83M$ -9.27M$ -9.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.36M$ 35.40M$ 28.90M$ 28.80M$ 35.00M
Total Assets$ 33.93M$ 40.14M$ 34.02M$ 34.42M$ 39.18M
Total Debt$ 863.00K$ 939.00K$ 1.01M$ 1.09M$ 1.16M
Net Debt$ -28.50M$ -34.46M$ -27.89M$ -27.71M$ -33.84M
Total Liabilities$ 62.22M$ 61.95M$ 49.93M$ 47.27M$ 44.16M
Stockholders Equity$ -28.29M$ -21.81M$ -15.91M$ -12.85M$ -4.97M
Cash Flow-
Free Cash Flow$ -6.10M$ -7.91M$ 375.00K$ -6.52M$ -6.44M
Operating Cash Flow$ -5.68M$ -7.85M$ 495.00K$ -6.08M$ -5.34M
Investing Cash Flow$ -11.44M$ -57.00K$ -120.00K$ -445.00K$ -1.10M
Financing Cash Flow-$ 14.34M$ -257.00K$ 317.00K$ 22.00K
Currency in USD

Clearside Biomedical Earnings and Revenue History

Clearside Biomedical Debt to Assets

Clearside Biomedical Cash Flow

Clearside Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis